1887
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Spatially gradated segregation and recovery of circulating tumor cells from peripheral blood of cancer patients
Rent:
Rent this article for
USD
10.1063/1.4808456
/content/aip/journal/bmf/7/3/10.1063/1.4808456
http://aip.metastore.ingenta.com/content/aip/journal/bmf/7/3/10.1063/1.4808456

Figures

Image of FIG. 1.
FIG. 1.

Microfluidic device for CTC detection, capture, and recovery. (a) Design of the chip. (b) Pre-filter with a gap space of 50 m to minimize blood clogging. (c) Enlarged view of the cells capture region. The size distribution of the micro pillars varies from 12 m down to 4 m. (d) Details of the connection setup with a syringe pump to drive the cells through the microfluidic chip.

Image of FIG. 2.
FIG. 2.

(a) Cell capture chamber depicting trapped Hela. (b) The ranges from a high of 95% to a low of 74% for the 4 flow rates (0.5, 1.0, 1.5, 2.0 ml/h) being studied. (c) A comparison of the 5-day cell proliferation process between captured cells (at the max flow rate of 2 ml/h) and normal cultured cells shows no perceptible difference between them. Thus, it appears that the viability of the cancer cells is unaffected by the 4 flow rates used for their capture. Further, our micropillars are designed with an unusual shape to minimize damage to a cell caught in-between 2 micropillars. Scale bar is 100 m.

Image of FIG. 3.
FIG. 3.

A comparison of the severity of blood clots in the capture region of the chip when working with (a) unlysed blood versus (b) lysed blood.

Image of FIG. 4.
FIG. 4.

(a) Bright field and fluorescence and merged images in the microfluidic chip. Hela and WBCs are marked with red and green fluorescence, respectively. Scale bar is 10 m. (b) The of the chip seems to be unaffected by the varying flow rates.

Image of FIG. 5.
FIG. 5.

Positive CTC enumeration was detected in all blood samples taken from patients with liver cancer. (a) CTC count per 3-ml blood sample and it ranged from a low of 1–2 (1 patient) to a high of >20 (2 patients). (b) Captured cells from blood of liver cancer patients. Scale bar is 10 m. (c) Immunofluorescence staining is performed on recovered CTCs. To distinguish the inadvertently captured WBCs from the captured CTCs, the former are stained with blue and red fluorescence, while the latter are stained with blue and green fluorescence. The merged slide clearly depicts the distinction between the 2 cell types. Scale bar is 10 m.

Tables

Generic image for table
Table I.

Antibody-independent technology for CTC segregation, capture, and recovery.

Loading

Article metrics loading...

/content/aip/journal/bmf/7/3/10.1063/1.4808456
2013-06-06
2014-04-25
Loading

Full text loading...

This is a required field
Please enter a valid email address
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
Scitation: Spatially gradated segregation and recovery of circulating tumor cells from peripheral blood of cancer patients
http://aip.metastore.ingenta.com/content/aip/journal/bmf/7/3/10.1063/1.4808456
10.1063/1.4808456
SEARCH_EXPAND_ITEM